Godrej Properties, a leading real estate developer in India, has seen its share price plunge to 52-week lows. Despite this, the company has been aggressively expanding its portfolio by acquiring 12 land parcels between April and June.
Real EstateShare PriceGodrej PropertiesExpansionSustainabilityReal EstateFeb 17, 2025
Godrej Properties' share price has hit a 52-week low, reflecting the current market volatility in the real estate sector.
Godrej Properties has acquired 12 land parcels between April and June, further expanding its portfolio and market presence.
Godrej Properties is focusing on delivering high-quality projects, investing in technology and sustainability, and expanding its footprint in key cities.
Godrej Bella Verde, a sustainable residential complex in NCR, is one of the notable projects that has garnered significant interest from eco-conscious buyers.
Godrej Properties has ventured into the affordable housing segment, aligning with the government's 'Housing for All' initiative to capitalize on the growing demand in this area.
Discover 10 countries that offer residency to foreign investors through real estate investment programs
After Amitabh Bachchan and Kriti Sanon, Kushal Tandon buys a 2002 sq ft plot in Alibaug, a prime second home destination near Mumbai, for ₹2 crore.
The government has proposed significant relief for taxpayers in terms of capital gains tax on real estate properties, giving them the option of paying a 20% tax rate with indexation or a 12.5% tax rate without indexation.
The Maharashtra government has given the green light to invest Rs 500 billion in various infrastructure projects in Mumbai, aiming to boost the city's real estate market and overall economy.
Promoters of Metro Brand Ltd. have recently secured five luxurious apartments in the prestigious Palais Royale, Lower Parel, for a total value of Rs 405 crore. Each property comes with five car parkings and a per square foot (PSF) rate ranging from Rs 1,0
Explore the long-term implications of weight-loss drugs like Ozempic and the potential for ongoing treatment. Understand the benefits, risks, and what the future holds for patients using these medications.